StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Aristotle to be launched in Q1

<< Previous

Bullboard Posts

Next >>

Comment by RelevantStockon Dec 08, 2020 9:30am

163 Views

Post# 32056800

RE:RE:RE:RE:RE:Aristotle to be launched in Q1

Bully88 wrote: This is HUGE news

Mentioning this on an Analyst Conference Call is not a whisper.

Expect the news release for this to come closer to launch date.

This company is going to be fcuking massive.

100 Bagger in the making

Congrats to everyone who buys below 4$

Cheers,

Bully

I really love how he mentionned they have a technological lead on the competitors with Aristotle

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?